Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services (NYSE American: AMS) regularly issues news updates that describe its role as a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services. Its press releases highlight developments across its medical equipment leasing and direct patient care services segments, giving investors and observers insight into how the company’s cancer treatment–focused operations are evolving.
News items frequently cover quarterly and annual financial results, where the company reports revenue from Gamma Knife, linear accelerator (LINAC), and proton beam radiation therapy, as well as performance in its direct patient care services segment. These releases often include management commentary on treatment volumes, contract activity, new center openings, and the balance between leasing and direct patient care services.
American Shared Hospital Services’ news flow also emphasizes business expansion and partnerships. Recent disclosures reference acquiring majority interests in radiation therapy treatment centers in Rhode Island, opening a radiation therapy center in Puebla, Mexico, and planning additional radiation therapy and proton beam centers under Certificate of Need approvals. The company’s descriptions of turnkey solutions for cancer treatment centers, health systems, and cancer networks in North and South America are a recurring theme in its announcements.
Regulatory and corporate governance updates appear in the form of conference call announcements, shareholder meeting notices, and SEC-related disclosures. These include scheduling of earnings calls, participation in investor conferences, and information about annual shareholder meetings. Together, the AMS news feed on this page provides a centralized view of the company’s reported financial performance, operational changes in its cancer treatment services, and key corporate events.
American Shared Hospital Services (AMS) will hold a quarterly conference call on May 13, 2021, at 1:00 PM EST to discuss its first quarter 2021 financial results. The press release detailing these results will be published premarket on the same day. AMS is known for advancing technology solutions in stereotactic radiosurgery and advanced radiation therapy. The company specializes in Gamma Knife radiosurgery and offers other cutting-edge treatment systems. For further details, visit www.ashs.com.
American Shared Hospital Services (NYSE American: AMS) announced its Annual Meeting of Shareholders will be held virtually on June 25, 2021, at 8:00 a.m. PST due to the COVID-19 pandemic. April 26, 2021, is set as the record date for determining shareholders entitled to vote. The company specializes in providing advanced technology solutions for stereotactic radiosurgery and radiation therapy, including Gamma Knife and proton therapy systems. The press release also includes a safe harbor statement discussing potential risks such as market conditions and financial variability.
American Shared Hospital Services (AMS) has secured a $22 million credit agreement with Fifth Third Bank, closing on April 9, 2021. The agreement comprises three loan facilities: a $9.5 million term loan for refinancing Gamma Knife debt and future projects, a $5.5 million term loan for PBRT Orlando equipment debt and working capital, and a $7 million revolving line of credit for increased project negotiation flexibility. This financing aims to lower costs, enhance cash generation, and support AMS's growth strategy in the advanced radiation therapy market.
American Shared Hospital Services (NYSE American: AMS) reported Q4 2020 revenues of $4,608,000, a 3.7% decrease from Q4 2019. Proton therapy revenue fell to $1,403,000 (-5.6%), while Gamma Knife revenue decreased slightly by 0.8% to $3,205,000. Operating loss was $8,543,000, markedly down from a profit a year earlier, largely due to an $8,264,000 asset impairment charge. Net loss increased to $6,231,000 from a profit of $193,000 in Q4 2019. Despite these challenges, CEO Ray Stachowiak indicated plans for growth and operational recovery in 2021, with a stronger cash position of $4.3 million.
American Shared Hospital Services (NYSE American: AMS) reported Q3 2020 financials, revealing total revenue of $4,670,000, down 11.9% year-over-year but up 17.0% from Q2 2020. Proton therapy revenue remained flat year-over-year at $1,687,000, while Gamma Knife revenue decreased 9.9% to $2,983,000. The company experienced a net loss of $209,000, contrasting with a net income of $165,000 in Q3 2019. Notably, cash reserves increased to $3.6 million. The CEO highlighted a focus on expense management and potential growth in revenue streams.
American Shared Hospital Services (NYSE American: AMS) announced a quarterly conference call scheduled for November 12, 2020, at 3:00 pm EST. The call will discuss the company’s financial results for the third quarter of 2020, which will be released premarket on the same day. Interested parties can participate by calling 1 (888) 466-9845 and entering passcode 6465095#. The event will also be available via a simultaneous webcast on the company's website. A replay will be accessible until November 26, 2020.
American Shared Hospital Services (NYSE American: AMS) has appointed Raymond C. Stachowiak as Chief Executive Officer, effective October 1, 2020. Stachowiak has been with the company since 2009 and was serving as Interim President and CEO. Alongside this, Craig K. Tagawa becomes President and continues as Chief Operating and Financial Officer, while Ernest R. Bates is promoted to lead International Operations. The board expresses confidence in Stachowiak's leadership to drive future growth in advanced radiosurgical and radiation therapy services.
American Shared Hospital Services (AMS) reported significant financial impacts from the COVID-19 pandemic for Q2 2020. Total revenue fell by 23.2% to $3,991,000 compared to Q2 2019. While proton therapy revenue remained stable at $1,401,000, Gamma Knife revenue plummeted by 28.1% to $2,590,000. The company suffered a net loss of $483,000 versus net income of $31,000 in the previous year. Adjusted EBITDA also declined to $1,437,000. Despite challenges, AMS is seeing early signs of volume recovery in July.
American Shared Hospital Services (AMS) will hold its Annual Meeting of Shareholders virtually on June 26, 2020, at 9:00 a.m. PT, due to COVID-19. Shareholders can participate by registering online and using their unique control numbers to vote. Registration requires a legal proxy from intermediaries by June 16, 2020. The meeting's agenda and voting instructions will be accessible on the meeting site. The company remains committed to providing advanced radiation therapy solutions, including Gamma Knife and proton therapy, amidst ongoing uncertainties from the pandemic.
American Shared Hospital Services (NYSE American: AMS) will hold a quarterly conference call on May 11, 2020, at 3:00pm EDT to discuss its first quarter 2020 financial results. The results will be released premarket on the same day. Interested participants can join the call by dialing 1 (877) 420-2982 and entering passcode 9311758#. A simultaneous webcast will be accessible via the company's website. A playback of the call will be available until June 10, 2020, using passcode 49677167.